137 related articles for article (PubMed ID: 4130388)
1. Complement factors and the growth of Ehrlich's carcinoma.
Thunold S; Horseide V; Hartveit F
Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Jun; 81(3):373-81. PubMed ID: 4130388
[No Abstract] [Full Text] [Related]
2. [Changes in serum proteins in mice with Ehrlich's tumor].
Billitteri A; Brucchieri A
Sperimentale; 1969; 119(6):435-46. PubMed ID: 4109068
[No Abstract] [Full Text] [Related]
3. Interaction of transplants of the Ehrlich carcinoma. Lack of local reaction to subcutaneous transplants in the presence of late intraperitoneal tumour.
Hartveit F; Cater DB
Acta Pathol Microbiol Scand A; 1971; 79(5):423-31. PubMed ID: 4107703
[No Abstract] [Full Text] [Related]
4. [Morphological changes of the cells of Ehrlich's experimental ascites carcinoma in the course of immunological lysis].
Chibowski D
Ann Univ Mariae Curie Sklodowska Med; 1964; 19():465-78. PubMed ID: 4159442
[No Abstract] [Full Text] [Related]
5. Use of Ehrlich's ascitic tumour cells in preparing hyperimmune fluid against third component (C3) of human serum complement.
Gupta AK; Rao KM; Manja KS
Indian J Exp Biol; 1980 May; 18(5):532-3. PubMed ID: 6776040
[No Abstract] [Full Text] [Related]
6. Globulin coating in vivo of Ehrlich's ascites carcinoma cells.
Thunold S
Transplantation; 1968 Aug; 6(5):716-27. PubMed ID: 4179287
[No Abstract] [Full Text] [Related]
7. Histological demonstration of a biphasic acute inflammatory response to subcutaneous transplants of Ehrlich's carcinoma.
Hartveit F; Halleraker B
Acta Pathol Microbiol Scand A; 1971; 79(1):43-52. PubMed ID: 5546543
[No Abstract] [Full Text] [Related]
8. [On the presence of substances with anti-complement activity in the blood and ascitic fluid in Ehrlich's tumor in mice].
Carretti N
Boll Soc Ital Biol Sper; 1969 Apr; 45(8):470-4. PubMed ID: 5369737
[No Abstract] [Full Text] [Related]
9. The induction of a fatal desmoplastic mesothelial reaction in rabbits with mouse Ehrlich ascites carcinomata.
Sinai Y; Reesal MR
J Pathol; 1974 Mar; 112(3):129-37. PubMed ID: 4209683
[No Abstract] [Full Text] [Related]
10. Quantitation of in vivo growth of plasmacytoma X5563 by immunoassay for its paraprotein with individual antigenic specificity.
Yutoku M; Seno H; Watanabe S; Matsuoka Y; Kitagawa M
J Natl Cancer Inst; 1972 Nov; 49(5):1395-402. PubMed ID: 4119497
[No Abstract] [Full Text] [Related]
11. [Antineoplastic immunological reactions in animals with Ehrlich's carcinoma].
Bergamini G; D'Acunzo L; Fazio G; Giudici G
Riv Patol Clin Sper; 1967; 8(4):477-88. PubMed ID: 5605966
[No Abstract] [Full Text] [Related]
12. THE EFFECTS OF ANTIBODIES ON CELLS. II. CHANGES IN THE ELECTROPHORETIC MOBILITY OF ASCITES TUMOUR CELLS TREATED WITH ANTIBODIES AND COMPLEMENT.
FORRESTER JA; DUMONDE DC; AMBROSE EJ
Immunology; 1965 Jan; 8(1):37-48. PubMed ID: 14245310
[TBL] [Abstract][Full Text] [Related]
13. The host response of irradiated mice to Ehrlich's ascites carcinoma.
Thunold S
Acta Pathol Microbiol Scand; 1966; 68(1):37-46. PubMed ID: 5954972
[No Abstract] [Full Text] [Related]
14. What are the immune responses during the growth of Ehrlich's tumor in ascitic and solid form?
Feitosa IB; Mori B; Teles CBG; Costa AGD
Life Sci; 2021 Jan; 264():118578. PubMed ID: 33058910
[TBL] [Abstract][Full Text] [Related]
15. Reactions in agarose gel between C1q and aggregated gamma globulin.
Thunold S; Abeyounis CJ; Milgrom F
J Immunol; 1970 Mar; 104(3):685-90. PubMed ID: 4190971
[No Abstract] [Full Text] [Related]
16. Immunologic enhancement of tumor xenografts by pepsin-degraded immunoglobulin.
Broder S; Whitehouse F
Science; 1968 Dec; 162(3861):1494-5. PubMed ID: 4177430
[TBL] [Abstract][Full Text] [Related]
17. Effect of Proteus vulgaris lipopolysaccharide on resistance of mice inoculated with tumor cells sensitized to Ehrlich carcinoma transplantation.
Kato N; Ito S; Yamazaki M; Mizuno D
Gan; 1973 Apr; 64(2):111-20. PubMed ID: 4124878
[No Abstract] [Full Text] [Related]
18. [Tween 80 and immunological defense against Ehrlich's ascitic carcinoma].
Castagnone Prati D; Di Roberto F; Ingrami A
Arch Ital Patol Clin Tumori; 1967; 10(1):29-35. PubMed ID: 5600139
[No Abstract] [Full Text] [Related]
19. Serological studies of antigenic changes occurring in two lines of Ehrlich's ascites tumor after long periods of cultivation in vitro.
Monti-Bragadin C; Kieler J
Eur J Cancer (1965); 1968 Jul; 4(3):255-61. PubMed ID: 5760800
[No Abstract] [Full Text] [Related]
20. The inactivator of the first component of human complement (C1INA). The complex formation with the activated first component of human complement (C1) or with its subcomponents.
Nagaki K; Iida K; Inai S
Int Arch Allergy Appl Immunol; 1974; 46(6):935-48. PubMed ID: 4210434
[No Abstract] [Full Text] [Related]
[Next] [New Search]
